Immunoassay Biomarkers Evaluated for Preeclampsia Diagnosis
Preeclampsia is one of the leading hypertensive disorders in pregnant women worldwide and it is estimated to cause more than 60,000 deaths per year. Preeclampsia is induced by placental and maternal vascular dysfunction, which affects both maternal and neonatal health.
Latest News
- Increased Probability of Sepsis Mortality Associated with SOFA Score
- Cytokine Concentration Linked to Chronic Fatigue Syndrome
- Mutations Related to Hereditary Neuroendocrine Tumors
- Biomarkers Lead to Better Prognosis for CF Patients
- Blood Test Detects Brain Metastases While Treatable
- Neurological Disease Traced to Gene Error
- Expanded Pathogen Identification Receives FDA Clearance
- Three Commercial Tests for Lyme Borreliosis Evaluated
